BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7037351)

  • 1. [Des-phe-insulin-containing intermediary insulin compared with usual commercial preparations (author's transl)].
    Sachse G; Mäser E; Schäfer D; Federlin K
    Dtsch Med Wochenschr; 1982 Mar; 107(9):332-5. PubMed ID: 7037351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
    Sachse G; Federlin K
    Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.
    Santeusanio F; Massi-Benedetti M; Clementi A; Calabrese G; Bueti A; Picchio E; Brunetti P
    Diabete Metab; 1981 Sep; 7(3):173-9. PubMed ID: 7033008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of diabetic patients with Optisulin-Depot CR in comparison with Depot-Insulin Hoechst klar CR--therapeutic progress?].
    Kacerovsky-Bielesz G; Hohenecker J; Schindler H
    Wien Med Wochenschr; 1983 Jan; 133(2):49-52. PubMed ID: 6342276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diabetes during pregnancy with Des-Phe insulin: preliminary results (author's transl)].
    Peters FD; Dilger J; Roemer VM
    Dtsch Med Wochenschr; 1979 Jul; 104(27):973-5. PubMed ID: 572289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of diabetic patients with insulin resistance and allergy using des-phe-insulin (author's transl)].
    Valdenaire K; Klein W
    Dtsch Med Wochenschr; 1979 Nov; 104(46):1637-9. PubMed ID: 499001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with a chemically modified monospecies-insulin].
    Sailer D; Kolb S
    Med Klin; 1981 Aug; 76(17):479-81. PubMed ID: 7024762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of NPH insulin (author's transl)].
    Roesner M; Sauer H
    Dtsch Med Wochenschr; 1976 Jun; 101(23):886-9. PubMed ID: 1269430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term therapy with human insulin. Clinical experiences].
    Sachse G; Mäser E; Federlin K
    Dtsch Med Wochenschr; 1985 Mar; 110(11):403-6. PubMed ID: 3884307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
    Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
    Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with Des-Phe B1 insulins].
    Hasche H; Willms B
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():779-82. PubMed ID: 1029281
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice].
    Petunina NA; Balabolkin MI; Mkrtumian AM; Sergeev AV; Nedosugova LV
    Ter Arkh; 1993; 65(10):29-31. PubMed ID: 8296229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patterns of allergic skin reactions during insulin treatment (author's transl)].
    Hasche H; Haslbeck M; Bachmann W; Mehnert H
    Dtsch Med Wochenschr; 1981 Oct; 106(44):1451-6. PubMed ID: 7028442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
    Saner B; Fankhauser S
    Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterisation of activity of a biphasic monocomponent insulin (author's transl)].
    Neubauer M; Althoff PH; Schnabel O; Genrich V; Schöffling K
    Dtsch Med Wochenschr; 1979 Mar; 104(11):384-90. PubMed ID: 421667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD; Duncan LJ; Clarke BF
    Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment with Des-Phe-Insulin].
    Hirn S; Pietschmann H
    Wien Klin Wochenschr; 1982 Dec; 94(24):662-5. PubMed ID: 6820587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of purified bovine and monocomponent porcine insulins.
    Johnson Z; McDonnell J; Devlin JG
    Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
    Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
    Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.